Literature DB >> 7961200

Bacteriology of selective decontamination: efficacy and rebound colonization.

G W Tetteroo1, J H Wagenvoort, H A Bruining.   

Abstract

In earlier studies concerning the use of selective decontamination (SD) we recognized some patients to have an incomplete or failed decontamination which had negative consequences for their outcome. We also experienced patients to have a rebound colonization with potentially pathogenic microorganisms (PPM) after the withdrawal of SD medication, thereby endangering the hospital environment as sources of possibly resistant microorganisms. In a prospective observational cohort-study, we have studied 135 patients on a surgical ICU in a University hospital. On admission 51% of all patients harboured PPM, of which 64% and 79% were eliminated form the oropharynx and gut, respectively. A total of 49 episodes of SD (32%) had to be defined as ineffective, partly due to late or inadequate administration of medication. Rebound colonization with nosocomial aerobic PPM was seen in 20 of 90 successfully decontaminated episodes, but there were no infections. Eighty-four of 123 surveillance cultures (68%) revealed a complete recolonization with flora in a composition not different from the pre-admission flora. Withdrawal of SD medication 5 days after extubation proved satisfactory because no infections ensued. Surveillance cultures are obligatory to determine whether SD is effective as one third of patients receiving SD experienced bacterial colonization with PPM and therefore had no benefit from this prophylaxis. In addition, these results indicate that an intact and functional colonization resistance develops in patients after cessation of effective SD medication, but only when physiological defence mechanisms are presumably restored. In the seven years of experience with SD, increasing antibiotic resistance has not been in the study hospital.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961200     DOI: 10.1093/jac/34.1.139

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

Review 1.  All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth.

Authors:  Hendrick K F van Saene; Andy J Petros; Graham Ramsay; Derrick Baxby
Journal:  Intensive Care Med       Date:  2003-04-10       Impact factor: 17.440

Review 2.  Selective decontamination of the digestive tract: 13 years on, what it is and what it is not.

Authors:  D Baxby; H K van Saene; C P Stoutenbeek; D F Zandstra
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

3.  Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomized, placebo-controlled, double-blind trial.

Authors:  Miguel A de La Cal; Enrique Cerdá; Paloma García-Hierro; Hendrick K F van Saene; Dulce Gómez-Santos; Eva Negro; José Angel Lorente
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

4.  The effect of selective decontamination of the digestive tract on mortality in multiple trauma patients: a multicenter randomized controlled trial.

Authors:  C P Stoutenbeek; H K F van Saene; R A Little; A Whitehead
Journal:  Intensive Care Med       Date:  2006-12-05       Impact factor: 17.440

5.  Selective decontamination of the gastrointestinal tract in patients undergoing esophageal resection.

Authors:  Franziska Näf; René Warschkow; Walter Kolb; Michael Zünd; Jochen Lange; Thomas Steffen
Journal:  BMC Surg       Date:  2010-12-16       Impact factor: 2.102

6.  Incidence of coagulase-negative staphylococcal bacteremia among ICU patients: decontamination studies as a natural experiment.

Authors:  James C Hurley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-04       Impact factor: 3.267

7.  Structural equation modelling the relationship between anti-fungal prophylaxis and Pseudomonas bacteremia in ICU patients.

Authors:  James C Hurley
Journal:  Intensive Care Med Exp       Date:  2022-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.